Protagenic Therapeutics, Inc.\new SEC filings PTIX
Protagenic Therapeutics, Inc.\new has 705 filings in SEC EDGAR's recent list, going back to Oct 22, 1996. Its latest annual report, Form 10-K, was filed on Aug 14, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 20, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Aug 14, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | May 14, 2024 | Dec 31, 2023 |
| 10-K/A | Amended annual report | Apr 24, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 10-K/A | Amended annual report | Apr 17, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Apr 7, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 25, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Apr 29, 2020 | Dec 31, 2019 |
| 10-K/A | Amended annual report | Jul 3, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 29, 2019 | Dec 31, 2018 |
| 10-K/A | Amended annual report | Apr 5, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Apr 2, 2018 | Dec 31, 2017 |
| 10-K/A | Amended annual report | May 8, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Apr 18, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Sep 25, 2015 | Jun 30, 2015 |
| 10-K | Annual report | Oct 14, 2014 | Jun 30, 2014 |
| 10-K/A | Amended annual report | May 2, 2011 | Dec 31, 2010 |
| 10-K | Annual report | Apr 7, 2011 | Dec 31, 2010 |
| 10-K/A | Amended annual report | Apr 30, 2010 | Dec 31, 2009 |
| 10-K | Annual report | Mar 31, 2010 | Dec 31, 2009 |
| 10-K | Annual report | Mar 27, 2009 | Dec 31, 2008 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PTIX (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1022899
- Former names
- Atrinsic, Inc. (until Jun 20, 2016); NEW MOTION, INC. (until Jun 30, 2009); MPLC, Inc. (until Apr 2, 2007); MILLBROOK PRESS INC (until May 23, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.